Wegovy

Wegovy® is a once-weekly injectable medication for chronic weight management, developed by the global pharmaceutical company Novo Nordisk. Since its launch, Wegovy has gained worldwide recognition and has become one of the most sought-after weight management treatments.

Its active ingredient, semaglutide, has demonstrated significant and sustained weight loss in clinical studies. Following its official launch in South Korea in October 2024, Wegovy has continued to experience exceptionally strong demand.